World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
83
Citations
24376
World Ranking
1449
National Ranking
97

Medicine

D-Index
85
Citations
25389
World Ranking
14653
National Ranking
775

Overview

Petra Reinke is affiliated with the Berlin-Brandenburger Centrum für Regenerative Therapien in Germany. Their research spans the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a focus on multiple subfields such as Oncology, Molecular Biology, Immunology, Transplantation, and Surgery.

The scientist's main topics of work include:

  • CAR-T cell therapy research
  • Renal Transplantation Outcomes and Treatments
  • CRISPR and Genetic Engineering
  • Immune Cell Function and Interaction
  • Cytomegalovirus and herpesvirus research
  • T-cell and B-cell Immunology
  • Viral Infectious Diseases and Gene Expression in Insects

Among recent publications authored or co-authored by Petra Reinke are:

  • Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials, 2020, The Lancet
  • MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy, 2020, Frontiers in Immunology
  • Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial, 2020, BMJ
  • Toward an Optimized Process for Clinical Manufacturing of CAR-Treg Cell Therapy, 2020, Trends in biotechnology
  • Pharmacological interventions enhance virus-free generation of TRAC-replaced CAR T cells, 2022, Molecular Therapy - Methods & Clinical Development

The scientist frequently publishes in several venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Molecular Therapy - Methods & Clinical Development
  • Molecular Therapy
  • Frontiers in Cell and Developmental Biology

Collaborations include frequent co-authorship with:

  • Hans-Dieter Volk
  • Michael Schmueck-Henneresse
  • Dimitrios L. Wagner
  • Nina Babel
  • Maik Stein

Petra Reinke's research contributions are distributed primarily across the medical sciences, with extensive involvement in oncology, immunology, and transplantation, reflecting both clinical and molecular research dimensions.

Best Publications

  • Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.

    Christian Meisel;Joerg C. Schefold;Rene Pschowski;Tycho Baumann

  • Monocyte deactivation--rationale for a new therapeutic strategy in sepsis.

    H D Volk;P Reinke;D Krausch;H Zuckermann

  • Comparison of adefovir and tenofovir in the treatment of lamivudine‐resistant hepatitis B virus infection

    Florian van Bömmel;Thomas Wünsche;Stefan Mauss;Petra Reinke

  • CARBON NITRIDE DEPOSITED USING ENERGETIC SPECIES: A REVIEW ON XPS STUDIES

    C. Ronning;H. Feldermann;R. Merk;H. Hofsäss

  • Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

    Ralf Trappe;Stephan Oertel;Veronique Leblond;Peter Mollee

  • Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines.

    Guido Moll;James A. Ankrum;James A. Ankrum;Julian Kamhieh-Milz;Karen Bieback;Karen Bieback

  • Protection from cytomegalovirus after transplantation is correlated with immediate early 1–specific CD8 T cells

    Torsten Bunde;Alexander Kirchner;Bodo Hoffmeister;Dirk Habedank

  • Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial.

    Klemens Budde;Thomas Becker;Wolfgang Arns;Claudia Sommerer

  • Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.

    Nils Lachmann;Paul I. Terasaki;Klemens Budde;Lutz Liefeldt

  • Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.

    Birgit Sawitzki;Paul N Harden;Petra Reinke;Aurélie Moreau

  • High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population

    Dimitrios L. Wagner;Leila Amini;Desiree J. Wendering;Lisa-Marie Burkhardt

  • Target Structures of the CD8+-T-Cell Response to Human Cytomegalovirus: the 72-Kilodalton Major Immediate-Early Protein Revisited

    Florian Kern;Ingolf Pascal Surel;Nicole Faulhaber;Claudia Frömmel

  • Terminally Differentiated CD8+ T Cells Negatively Affect Bone Regeneration in Humans

    Simon Reinke;Sven Geissler;William R. Taylor;Katharina Schmidt-Bleek

  • Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor.

    E Fietze;S Prösch;P Reinke;J Stein

  • T-CELL EPITOPE MAPPING BY FLOW CYTOMETRY

    Florian Kern;Ingolf Pascal Surel;Carsten Brock;Bernd Freistedt

  • Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals

    Florian Kern;Torsten Bunde;Nicole Faulhaber;Nicole Faulhaber;Felix Kiecker

  • Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides.

    Florian Kern;Nicole Faulhaber;Claudia Frömmel;Elham Khatamzas

  • Clinical aspects: from systemic inflammation to 'immunoparalysis'.

    H D Volk;P Reinke;W D Döcke

  • Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD)

    Stephan H.K. Oertel;Erik Verschuuren;Petra Reinke;Kristin Zeidler

  • Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms

    Joerg C. Schefold;Jan-Philip Zeden;Christina Fotopoulou;Stephan von Haehling

  • Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).

    Barbara Savoldo;John A. Goss;John A. Goss;Markus M. Hammer;Markus M. Hammer;Lan Zhang;Lan Zhang

Frequent Co-Authors

Hans-Dieter Volk
Hans-Dieter Volk Charité - University Medicine Berlin
Klemens Budde
Klemens Budde Charité - University Medicine Berlin
Birgit Sawitzki
Birgit Sawitzki Charité - University Medicine Berlin
Ioannis Anagnostopoulos
Ioannis Anagnostopoulos Charité - University Medicine Berlin
Peter Neuhaus
Peter Neuhaus Charité - University Medicine Berlin
Stefan G. Tullius
Stefan G. Tullius Brigham and Women's Hospital
Rolf A.K. Stahl
Rolf A.K. Stahl Universität Hamburg
Martin Dreyling
Martin Dreyling Ludwig-Maximilians-Universität München
Robert Sabat
Robert Sabat Charité - University Medicine Berlin
Véronique Leblond
Véronique Leblond Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology often aligns with careers in healthcare and research, but many students also explore related fields such as Nursing, especially advanced practice roles. For those interested in combining patient care with immunology expertise, exploring the cheapest psych np programs online can provide an affordable path to becoming a Psychiatric Nurse Practitioner, a specialty increasingly relevant in holistic patient treatment.

Career advancement in nursing often depends on specialized education. For those aiming to increase their clinical expertise, understanding dnp salary by specialty can offer insights into the financial benefits attached to various advanced nursing degrees.

Many nurses look to refine their skills or shift specialties. Programs like the fnp to acute care np bridge program allow Family Nurse Practitioners to transition into acute care settings, providing flexibility and expanding career options within healthcare.

For registered nurses seeking fast-tracked education, accelerated rn to np programs offer rigorous, time-efficient pathways to become Nurse Practitioners, integrating foundational nursing with advanced practice roles suitable for immunology-related clinical fields.

Best Scientists Citing Petra Reinke

Trending Scientists

Recently Published Articles